Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial

2018328 citationsJournal Articlegold Open Access

Authors

Clinicaltrials.gov identifier: NCT02155647.

Good health and well-being

Published in: Journal for ImmunoTherapy of Cancer

Volume 6, Issue 1, pp. 7-7

Field-Weighted Citation Impact: 21.33